Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05074810
Title Phase 1/2 Study of Avutometinib (VS-6766) + Sotorasib With or Without Defactinib in KRAS G12C NSCLC Patients (RAMP203)
Acronym RAMP203
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Verastem, Inc.
Age Groups: senior | adult
Covered Countries USA | NLD | GBR | FRA | ESP | BEL

No variant requirements are available.